Choose a section Top Retailers Supplier News OTC Pharmacy New Products Beauty Care
Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.
HAYWARD, Calif. — Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.
Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...
NEW YORK — Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the next year.
Sandoz has launched a generic version of a prostate drug, the generics arm of Novartis...
The Food and Drug Administration has approved the first generic version of a drug for...
